A Pilot Study to Compare the Antiviral and Immunologic Effects of Stavudine ( d4T ) Versus Placebo in Subjects With Evidence of Recent HIV Infection.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00002349|
Recruitment Status : Completed
First Posted : August 31, 2001
Last Update Posted : April 14, 2011
To compare the antiviral effect of stavudine ( d4T ) versus placebo in patients with evidence of recent HIV infection.
Also, to compare the immunologic effects and effects on quality of life of d4T in these patients.
|Condition or disease||Intervention/treatment||Phase|
|HIV Infections||Drug: Stavudine||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||40 participants|
|Intervention Model:||Single Group Assignment|
|Official Title:||A Pilot Study to Compare the Antiviral and Immunologic Effects of Stavudine ( d4T ) Versus Placebo in Subjects With Evidence of Recent HIV Infection.|
|Study Start Date :||January 1995|
|Actual Primary Completion Date :||May 1999|
|Actual Study Completion Date :||May 1999|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00002349
|United States, California|
|San Diego Naval Hosp|
|San Diego, California, United States, 921345000|
|United States, Virginia|
|Naval Med Ctr|
|Portsmouth, Virginia, United States, 237085100|
|United States, Washington|
|Northwest Med Ctr|
|Seattle, Washington, United States, 98122|
|Principal Investigator:||. ., .|